PHENOTYPES ASSOCIATED WITH TUMOR REJECTION MEDIATED BY CYCLOPHOSPHAMIDE AND SYNGENEIC TUMOR-SENSITIZED LYMPHOCYTES-T - POTENTIAL MECHANISMS OF ACTION

被引：39

作者：

EVANS, R

机构：

来源：

INTERNATIONAL JOURNAL OF CANCER | 1984年 / 33卷 / 03期

关键词：

D O I：

10.1002/ijc.2910330317

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：381 / 388

页数：8

共 24 条

[11] ENHANCEMENT OF DELAYED-HYPERSENSITIVITY REACTION WITH VARIETIES OF ANTI-CANCER DRUGS - A COMMON BIOLOGICAL PHENOMENON [J].

GOTO, M ;

MITSUOKA, A ;

SUGIYAMA, M ;

KITANO, M .

JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (01) :204-209

[12] ERADICATION OF DISSEMINATED MURINE LEUKEMIA BY CHEMO-IMMUNOTHERAPY WITH CYCLOPHOSPHAMIDE AND ADOPTIVELY TRANSFERRED IMMUNE SYNGENEIC LYMPHOCYTES-LYT-1+2- [J].

GREENBERG, PD ;

CHEEVER, MA ;

FEFER, A .

JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (03) :952-963

[13]

LECLERC JC, 1980, J IMMUNOL, V124, P846

[14] SEPARATION OF CELLS BY VELOCITY SEDIMENTATION [J].

MILLER, RG ;

PHILLIPS, RA .

JOURNAL OF CELLULAR PHYSIOLOGY, 1969, 73 (03) :191-&

[15] CONTRIBUTION OF HOST IMMUNITY TO CYCLOPHOSPHAMIDE THERAPY OF A CHEMICALLY-INDUCED MURINE SARCOMA [J].

MOORE, M ;

WILLIAMS, DE .

INTERNATIONAL JOURNAL OF CANCER, 1973, 11 (02) :358-368

[16] CYCLOPHOSPHAMIDE-FACILITATED ADOPTIVE IMMUNOTHERAPY OF AN ESTABLISHED TUMOR DEPENDS ON ELIMINATION OF TUMOR-INDUCED SUPPRESSOR T-CELLS [J].

NORTH, RJ .

JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (04) :1063-1074

[17]

RADOV LA, 1976, INT J CANCER, V17, P773, DOI 10.1002/ijc.2910170613

[18]

ROLLINGHOFF M, 1977, J EXP MED, V145, P455, DOI 10.1084/jem.145.2.455

[19]

ROSENBERG SA, 1982, PROG CANCER RES THER, V22, P161

[20]

RUSSELL PS, 1983, J IMMUNOL, V130, P951

← 1 2 3 →